The Eight Advisory Group continues its growth with the appointment of a new Partner to the Strategy team 

Anne Moore joins Eight Advisory as a Partner in the Strategy team in Paris. Holding a PhD in Pathophysiology and Human Genetics, and a Business Master’s degree in Pharmaceuticals Management, Anne brings nearly 20 years of professional experience in strategy consulting, investment, and executive roles in the pharmaceutical and medtech sectors across Europe and the United States. She brings a high-value combination of scientific expertise and business acumen to the life sciences ecosystem, supporting our pharma, biotech, medtech, and CRDMO clients to shape strategy and drive growth while guiding private equity and investor clients through commercial due diligence and investment decisions.  

Eric Demuyt, Managing Director of Eight Advisory Group, says:  

“We are delighted to welcome Anne to Eight Advisory. Her extensive sector expertise and international background strengthen our Strategy Consulting practice at a time when our clients face increasingly complex and global growth challenges. Her arrival reflects our ongoing ambition to expand our capabilities and support organisations in their key strategic decisions across Europe and beyond.

Nicolas Cohen Solal,Deputy Managing Director, in charge of the Strategy Consulting, comments:

“We are delighted to welcome Anne Moore as a Partner in our Strategy team. As an inspiring leader, Anne embodies scientific rigour, a multicultural outlook, and a genuine passion for developing teams. The healthcare advisory landscape is becoming increasingly demanding, requiring ever greater precision and specialised expertise. Her arrival represents a new milestone in strengthening our Life Sciences Strategy offering, complementing our existing operational and financial expertise to better support our clients.